Talkiatry

Talkiatry is a telepsychiatry platform connecting patients with psychiatrists for medication management — a mental health services company, not a drug developer. Its 100-point trial score reflects clinical research partnerships in mental health rather than its own therapeutic pipeline. Insider buying at 467 transactions is active. Talkiatry's direct-to-psychiatrist model addresses the severe shortage of psychiatric prescribers with a scalable digital platform, representing a mental health infrastructure play.

<article class="bts-verified-summary" data-ticker="TALK">
<p>Talkiatry (TALK) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>TALK has 6 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001803901 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22TALK%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>